Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population

被引:5
|
作者
Ma, Zhen-Bin [1 ]
Li, Kun [1 ]
Wang, Jian [1 ]
Guo, Guang-Hong [1 ]
机构
[1] Binzhou Med Coll, Affiliated Hosp, Dept Gastroenterol, Binzhou 256600, Peoples R China
关键词
Allele; KAI1/CD82; Colorectal cancer; Polymorphism; METASTASIS SUPPRESSOR GENE; CELL MOTILITY; TRANSMEMBRANE-4; SUPERFAMILY; CLINICAL-SIGNIFICANCE; DECREASED EXPRESSION; LYMPH-NODE; KAI1; CARCINOMA; PROTEINS; MUTATION;
D O I
10.1007/s12032-013-0668-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study is to investigate the associations between KAI1/CD82 gene polymorphisms and colorectal cancer (CRC)-risk predisposition. We undertook a case-control study to analyze two KAI1/CD82 polymorphisms (exon 3 -29166 C>T and exon 9 -52840 C>A) in an Han Chinese population, by extraction of genomic DNA from the peripheral blood of 356 patients with CRC and 378 control participants, and performed KAI1/CD82 genotyping using DNA sequencing. The obtained results indicated that overall, no statistically significant association was observed in exon 9 (-52840 C>A). Nevertheless, exon 3 (-29166 C>T) genotype was at increased risk of CRC (P = 0.006; odds ratio = 1.299, CI 95 % 1.058-1.549). Furthermore, -29166 T allele CRCs were more significantly common in patients with tumor size of >4 cm than C allele CRC and in cases of poor differentiation and advanced pathological stage. These findings led us to conclude that polymorphism in exon 3 (-29166 C>T) was observed to be associated with susceptibility of CRC. However, exon 9 (-52840 C>A) polymorphism showed no correlation to CRC susceptibility. Nevertheless, further investigation with a larger sample size is needed to support our results.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population
    Zhen-Bin Ma
    Kun Li
    Jian Wang
    Guang-Hong Guo
    Medical Oncology, 2013, 30
  • [2] Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
    Yan, Wei
    Huang, Jinny
    Zhang, Qian
    Zhang, Jian
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [3] KAI1/CD82, a tumor metastasis suppressor
    Liu, Wei M.
    Zhang, Xin A.
    CANCER LETTERS, 2006, 240 (02) : 183 - 194
  • [4] KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer
    Muneyuki, T
    Watanabe, M
    Yamanaka, M
    Shiraishi, T
    Isaji, S
    ANTICANCER RESEARCH, 2001, 21 (05) : 3581 - 3587
  • [5] A Potential Role of CD82/KAI1 during Uterine Decidualization in Mice
    Li, Qijun
    Song, Mengyao
    Cao, Ke
    Zhang, Qian
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 1799 - 1809
  • [6] Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer
    Al-Khater, Khulood M.
    Almofty, Sarah
    Ravinayagam, Vijaya
    Alrushaid, Noor
    Rehman, Suriya
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (06) : 3391 - 3398
  • [7] Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies
    Zhu, Jundong
    Miao, Chenkui
    Liu, Shouyong
    Tian, Ye
    Zhang, Chao
    Liang, Chao
    Xu, Aiming
    Cao, Qiang
    Wang, Zengjun
    ONCOTARGETS AND THERAPY, 2017, 10 : 5805 - 5816
  • [8] Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: Relationship to KAI1/CD82 levels and invasive behaviour
    Rowe, Alexandra
    Jackson, Paul
    ONCOLOGY REPORTS, 2006, 16 (06) : 1267 - 1272
  • [9] KAI1/CD82与恶性肿瘤
    张英兰
    国外医学(肿瘤学分册), 2001, (04) : 271 - 273
  • [10] Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma
    Yusenko, Maria V.
    Kovacs, Gyula
    HISTOPATHOLOGY, 2009, 55 (06) : 687 - 695